ARCH — Arch Biopartners Balance Sheet
0.000.00%
Last trade - 00:00
- CA$102.79m
- CA$108.07m
- CA$1.98m
R2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.4 | 0.654 | 0.448 | 0.506 | 0.831 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.14 | 0.061 | 2.2 | 0.087 | 0.297 |
Prepaid Expenses | |||||
Total Current Assets | 0.833 | 0.741 | 2.67 | 0.622 | 1.17 |
Total Assets | 0.833 | 0.741 | 2.67 | 0.622 | 1.17 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.585 | 1.22 | 3.19 | 2.78 | 5.98 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 3.47 | 4.61 | 6.55 | 5.09 | 6.68 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -2.64 | -3.87 | -3.88 | -4.47 | -5.51 |
Total Liabilities & Shareholders' Equity | 0.833 | 0.741 | 2.67 | 0.622 | 1.17 |
Total Common Shares Outstanding |